Patent · US Active

Indoleamine-2,3-dioxygenase inhibitor, preparation method therefor and use thereof

US11591301B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

HINOVA PHARMACEUTICALS INC. · CN

Inventors

Wu Du · Cranbury, US
Wen REN · Nanhu, CN
Haibin LV · Sichuan, CN
Haibo Li · Xiangtan City, CN
Kun Wen · Sichuan, CN
Jinyun He · Sichuan, CN
Dekun QIN · Sichuan, CN
Xinghai Li · North York, CA
Yuanwei Chen · Sichuan, CN

Key dates

Filing date	Jan 31, 2019
Grant date	Feb 28, 2023
Priority date	—
Expiry date	Jul 27, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound is represented by formula (I). A pharmaceutical composition contains the compound of formula (I). The compound is used in the preparation of an indoleamine-2,3-dioxygenase (IDO) inhibitor drug. The compound exhibits inhibition effect on IDO protease and metabolizes stably in the body. The compound or pharmaceutical composition thereof can be used for preparing an IDO inhibitor drug, and can also be used for preparing a drug for preventing and/or treating diseases having IDO-mediated tryptophan metabolic pathway pathological features.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.